Embedded Files
Cyclooxygenase 2 Inhibitors, or COX-2 inhibitors are used for treating conditions that cause inflammation, mild to moderate fever and pain. Data Bridge Market Research analyses that the cyclooxygenase 2 inhibitor market is estimated to grow at a CAGR of 10.50% during the forecast period of 2022 to 2029.
The world class CYCLOOXYGENASE 2 INHIBITORS MARKET report is an excellent resource to gain an in depth study about the present and upcoming opportunities to clarify the future investment in the market. This business report gives out the CAGR value fluctuation during the forecast period of 2021-2028 for the market. It has happened to be the necessary aspect of this rapidly changing market place to take up such market report which makes aware about the market environment. This market study estimates the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors. In addition, CYCLOOXYGENASE 2 INHIBITORS market analysis report also endows with top to bottom estimation of the market with respect to income and developing business sector.
The base year for calculation in the reliable CYCLOOXYGENASE 2 INHIBITORS market report is considered as 2020 while the historic year is 2019 which will tell how the market is going to perform in the forecast years. The market report also offers an analytical assessment of the prime challenges faced by the ABC industry currently and in the coming years, with which market participants can know the problems they may face while operating in this market over a longer period of time. An international CYCLOOXYGENASE 2 INHIBITORS market analysis report provides explanation about the detailed market analysis with inputs from industry experts.
Get the free sample copy of complete report here:
Market Analysis and Insights
Non-steroidal anti-inflammatory drugs (NSAIDs) are known to be one of the most widely used therapeutics owing to their anti-pyretic, analgesic and anti-inflammatory activities. Cyclooxygenase 2 Inhibitors refer to a subclass of nonsteroidal antiinflammatory drugs (NSAIDs) that work by reducing the production of prostaglandins. Prostaglandins chemicals promote pain, inflammation and fever.
Global Cyclooxygenase 2 Inhibitor Market
Drug Type
Celecoxib
Rofecoxib
Valdecoxib
Amlodipine
Others
On the basis of drug type, the cyclooxygenase 2 inhibitor market is segmented into celecoxib, rofecoxib, valdecoxib, amlodipine and others.
Types
Selective cox 2 inhibitor
Non-selective cox 2 inhibitor
On the basis of types, the cyclooxygenase 2 inhibitor market is segmented into selective cox 2 inhibitor and non-selective cox 2 inhibitor.
Indication
Osteoarthritis
Rheumatoid arthritis
Others
On the basis of Indication, the cyclooxygenase 2 inhibitor market is segmented into osteoarthritis, rheumatoid arthritis and others.
Route of Administration
Oral
Parenteral
Others
On the basis of route of administration, the cyclooxygenase 2 inhibitor market is segmented into oral, parenteral and others.
End-Users
Hospitals
Specialty Clinics
Others
On the basis of end-users, the cyclooxygenase 2 inhibitor market is segmented into hospitals, specialty clinics and others.
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
On the basis of distribution channel, the cyclooxygenase 2 inhibitor market is segmented into hospital pharmacy, retail pharmacy and others.
Pipeline Analysis
Some of the cyclooxygenase 2 inhibitor (COX-2 inhibitors) are widely utilized in a single dose to treat pain after surgery. Etoricoxib is considered better than other pain medications
and Celecoxib appears to be about as useful as ibuprofen. Pfizer Inc.
Bayer AG
Novartis AG
and Sabinsa
among others are some of the manufacturers involved with the development of cyclooxygenase 2 inhibitors.
Cyclooxygenase 2 Inhibitor Market Regional Analysis/Insights
The countries covered in the cyclooxygenase 2 inhibitor market report are U.S.
Canada and Mexico in North America
Germany
France
K.
Netherlands
Switzerland
Belgium
Russia
Italy
Spain
Turkey
Rest of Europe in Europe
China
Japan
India
South Korea
Singapore
Malaysia
Australia
Thailand
Indonesia
Philippines
Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
Saudi Arabia
A.E
South Africa
Egypt
Israel
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
Brazil
Argentina and Rest of South America as part of South America.
MAJOR TOC OF THE REPORT
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: cardiovascular information systems market
Get full Access of report
https://www.databridgemarketresearch.com/reports/global-cyclooxygenase-2-inhibitor-market
Get Toc of Report:
https://www.databridgemarketresearch.com/toc/?dbmr=global-cyclooxygenase-2-inhibitor-market
Browse Related Reports@
Global Chromatography Columns Market – Industry Trends and Forecast to 2029
Global Orthopedic Surgical Robots Market – Industry Trends and Forecast to 2029
The Global Insulin Storage Device Market
Global Surgery Device Market – Industry Trends and Forecast to 2027
Global DNA Markers Market – Industry Trends and Forecast to 2028
Global Neurorehabilitation Gaming Systems Market – Industry Trends and Forecast to 2028
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Page updated
Google Sites
Report abuse